Advertisement

Oral Radiology

, Volume 35, Issue 1, pp 77–83 | Cite as

Retrograde superselective intra-arterial chemoradiotherapy combined with hyperthermia and cetuximab for carcinoma of the buccal mucosa with N3 lymph node metastasis: a case report

  • Kaname Sakuma
  • Toshiyuki KoizumiEmail author
  • Kenji Mitsudo
  • Jun Ueda
  • Yuichiro Hayashi
  • Toshinori Iwai
  • Makoto Hirota
  • Mitomu Kioi
  • Haruka Yoshii
  • Hisashi Kaizu
  • Masaharu Hata
  • Akira Tanaka
  • Iwai Tohnai
Case Report
  • 85 Downloads

Abstract

We herein report a case of squamous cell carcinoma of the buccal mucosa with N3 cervical lymph node metastasis in a 63-year-old man. The patient was treated with combination therapy comprising radiotherapy (2 Gy/day, total of 70 Gy), superselective intra-arterial chemotherapy via a superficial temporal artery (docetaxel, total of 70 mg/m2 and cisplatin, total of 175 mg/m2), cetuximab (initial dose of 400 mg/m2 with subsequent weekly doses of 250 mg/m2 intravenously), and four sessions of hyperthermia for cervical lymph node metastases. The patient responded well to the therapy, with a complete response of the primary tumor. Radical neck dissection was performed with reconstructive surgery, including resection of the overlying skin. A pathologic complete response was achieved for the N3 and all other cervical lymph node metastases. The patient showed no evidence of recurrence in the 3 years following treatment. Based on the findings in the present case, the use of retrograde superselective intra-arterial chemoradiotherapy combined with hyperthermia and cetuximab seems to be a promising modality for patients with N3 cervical lymph node metastasis of oral cancer.

Keywords

Intra-arterial chemoradiotherapy Hyperthermia Cetuximab N3 cervical lymph node metastasis Oral cancer 

Notes

Compliance with ethical standards

Conflict of interest

Kaname Sakuma, Toshiyuki Koizumi, Kenji Mitsudo, Jun Ueda, Yuichiro Hayashi, Toshinori Iwai, Makoto Hirota, Mitomu Kioi, Haruka Yoshii, Hisashi Kaizu, Masaharu Hata, Akira Tanaka and Iwai Tohnai declare that they have no conflict of interest.

Human rights statement

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.

Informed consent

Informed consent was obtained from the patient for being included in the study. The patient provided permission for his photographs to be published.

References

  1. 1.
    Jacobs C, Makuch R. Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: a subset analysis of the Head and Neck Contracts Program. J Clin Oncol. 1990;8:838–47.CrossRefGoogle Scholar
  2. 2.
    Ahmed KA, Robbins KT, Wong F, Salazar JE. Efficacy of concomitant chemoradiation and surgical salvage for N3 nodal disease associated with upper aerodigestive tract carcinoma. Laryngoscope. 2000;110:1789–93.CrossRefGoogle Scholar
  3. 3.
    Carvalho AL, Kowalski LP, Agra IM, Ponites E, Campos OD, Pellizzon AC. Treatment results on advanced neck metastasis (N3) from head and neck squamous carcinoma. Otolaryngol Head Neck Surg. 2005;132:862–8.CrossRefGoogle Scholar
  4. 4.
    Tohnai I, Hayashi Y, Mitsudo K, Shigetomia T, Ueda M, Ishigaki T. Prognostic evaluation of preoperative thermochemoradiotherapy for N(3) cervical lymph node metastases of oral cancer. Oncology. 2002;62:234–40.CrossRefGoogle Scholar
  5. 5.
    Hattori T, Hirano T, Toyoda S, Nakagawa T, Yamaguchi N, Sakakura Y. Superselective continuous intra-arterial infusion therapy via superficial temporal artery for head and neck tumors. Nihon Igaku Hoshasen Gakkai Zasshi. 1985;45:1056–8. (articleJapanese).Google Scholar
  6. 6.
    Fuwa N, Ito Y, Matsumoto A, Kamata M, Kodaira T, Furutani K, et al. A combination therapy of continuous superselective intra-arterial carboplatin infusion and radiation therapy for locally advanced head and neck carcinoma. Phase I study Cancer. 2000;89:2099–105.Google Scholar
  7. 7.
    Tohnai I, Fuwa N, Hayashi Y, Kaneko R, Tomaru Y, Hibino Y, et al. New superselective intra-arterial infusion via superficial temporal artery for cancer of the tongue and tumour tissue platinum concentration after carboplatin (CBDCA) infusion. Oral Oncol. 1998;34:387–90.CrossRefGoogle Scholar
  8. 8.
    Mitsudo K, Shigetomi T, Fujimoto Y, Nishiguchi H, Yamamoto N, Furue H, et al. Organ preservation with daily concurrent chemoradiotherapy using superselective intra-arterial infusion via a superficial temporal artery for T3 and T4 head and neck cancer. Int J Radiat Oncol Bio Phys. 2011;79:1428–35.CrossRefGoogle Scholar
  9. 9.
    Mitsudo K, Koizumi T, Iida M, Iwai T, Nakashima H, Oguri S, et al. Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for stage III and IV oral cancer: analysis of therapeutic results in 112 cases. Radiother Oncol. 2014;111:306–10.CrossRefGoogle Scholar
  10. 10.
    Vermorken JB, Mesia R, Rivera F, Remenar E, Kawecki A, Rottey S, et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med. 2008;359:1116–27.CrossRefGoogle Scholar
  11. 11.
    Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006;345:567–78.CrossRefGoogle Scholar
  12. 12.
    Mitsudo K, Koizumi T, lida M, Iwai T, Oguri S, Yamamoto N, et al. Thermochemoradiation therapy using superselective intra-arterial infusion via superficial temporal and occipital arteries for oral cancer with N3 cervical lymph node metastases. Int J Radiat Oncol Biol Phys. 2012;83:e639–e45.CrossRefGoogle Scholar
  13. 13.
    Naruse T, Yanamoto S, Matsushita Y, Sakamoto Y, Morishita K, Ohba S, et al. Cetuximab for the treatment of locally advanced and recurrent/metastatic oral cancer: an investigation of distant metastasis. Mol Clin Oncol. 2016;5:246–52.CrossRefGoogle Scholar
  14. 14.
    Huilgol NG. A retrospective analysis of patients with head and neck cancer treated with radiation, hyperthermia, and cetuximab: a brief report of outcome. J Cancer Res Ther. 2016;12:1164–6.Google Scholar
  15. 15.
    Issels RD. Hyperthermia adds to chemotherapy. Eur J Cancer. 2008;44:2546–54.CrossRefGoogle Scholar
  16. 16.
    Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709–20.CrossRefGoogle Scholar
  17. 17.
    Mellin H, Friesland S, Lewensohn R, Dalianis T, Munck-Wikland E. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer. 2000;89:300–4.CrossRefGoogle Scholar
  18. 18.
    Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100:261–9.CrossRefGoogle Scholar
  19. 19.
    Dang J, Feng Q. HPV16 infection in oral cavity and oropharyngeal cancer patients. J Oral Sci. 2016;58:265–9.CrossRefGoogle Scholar

Copyright information

© Japanese Society for Oral and Maxillofacial Radiology and Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  • Kaname Sakuma
    • 1
    • 2
  • Toshiyuki Koizumi
    • 1
    Email author
  • Kenji Mitsudo
    • 1
  • Jun Ueda
    • 2
  • Yuichiro Hayashi
    • 1
  • Toshinori Iwai
    • 1
  • Makoto Hirota
    • 1
  • Mitomu Kioi
    • 1
  • Haruka Yoshii
    • 1
  • Hisashi Kaizu
    • 3
  • Masaharu Hata
    • 3
  • Akira Tanaka
    • 4
  • Iwai Tohnai
    • 1
  1. 1.Department of Oral and Maxillofacial SurgeryYokohama City University Graduate School of MedicineYokohamaJapan
  2. 2.Department of Oral and Maxillofacial Surgery, Niigata HospitalThe Nippon Dental UniversityNiigataJapan
  3. 3.Department of RadiologyYokohama City University Graduate School of MedicineYokohamaJapan
  4. 4.Department of Oral and Maxillofacial SurgeryThe Nippon Dental University School of Life Dentistry at NiigataNiigataJapan

Personalised recommendations